What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Oncolytic virus, Adenoviridae, Cancer research, Oncolytic adenovirus and Genetic enhancement.
Virus and Virology are closely tied to his Oncolytic virus research.
His Adenoviridae research is multidisciplinary, relying on both Gene expression and Gene delivery.
His studies deal with areas such as Genetics, Germline mutation and Immunology as well as Cancer research.
His research investigates the connection between Immunology and topics such as Cancer that intersect with problems in Disease and Gastroenterology.
His Genetic enhancement research is multidisciplinary, incorporating perspectives in Receptor, Ovarian cancer and Virotherapy.
His most cited work include:
- A serine/threonine kinase gene defective in Peutz–Jeghers syndrome (1347 citations)
- Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. (1226 citations)
- Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease (1024 citations)
What are the main themes of his work throughout his whole career to date?
Oncolytic virus, Cancer research, Oncolytic adenovirus, Cancer and Virology are his primary areas of study.
His research integrates issues of Adenoviridae, Genetic enhancement and Immunotherapy in his study of Oncolytic virus.
His Cancer research study integrates concerns from other disciplines, such as Tumor necrosis factor alpha, Cytokine, Cancer cell, Pathology and Viral vector.
His Oncolytic adenovirus research includes elements of Tumor microenvironment, Cancer immunotherapy, Cell killing and Virotherapy.
His biological study spans a wide range of topics, including Relative risk and Lung cancer, Oncology.
His study looks at the intersection of Virology and topics like In vivo with In vitro.
He most often published in these fields:
- Oncolytic virus (63.19%)
- Cancer research (53.22%)
- Oncolytic adenovirus (45.90%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (53.22%)
- Oncolytic adenovirus (45.90%)
- Oncolytic virus (63.19%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer research, Oncolytic adenovirus, Oncolytic virus, Cancer and Internal medicine.
Akseli Hemminki has included themes like Tumor necrosis factor alpha, T cell, Cytokine and Immunotherapy in his Cancer research study.
Oncolytic adenovirus is the subject of his research, which falls under Immune system.
His research on Oncolytic virus concerns the broader Virus.
His work on Prostate cancer as part of general Cancer research is often related to Cancer of unknown primary, thus linking different fields of science.
As a part of the same scientific study, Akseli Hemminki usually deals with the Internal medicine, concentrating on Oncology and frequently concerns with Melanoma, Risk factor, Lymphoma, Cancer registry and Squamous cell skin cancer.
Between 2016 and 2021, his most popular works were:
- Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (106 citations)
- Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses (90 citations)
- TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade (48 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary areas of study are Oncolytic adenovirus, Cancer research, Oncolytic virus, Cancer and Tumor microenvironment.
Part of his project on Oncolytic adenovirus includes research on Immune system and Immunology.
He interconnects T cell and Immunotherapy in the investigation of issues within Cancer research.
His Oncolytic virus research incorporates elements of Genetic enhancement and Pattern recognition receptor.
His Cancer research is multidisciplinary, relying on both Melanoma and Oncology.
His Tumor microenvironment study combines topics from a wide range of disciplines, such as Ex vivo, Tumor-infiltrating lymphocytes, Virus and Virotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
